203 related articles for article (PubMed ID: 32649312)
1. Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease.
Han L; Tang Y; Bai X; Liang X; Fan Y; Shen Y; Huang F; Wang J
Aging (Albany NY); 2020 Jul; 12(13):13518-13528. PubMed ID: 32649312
[TBL] [Abstract][Full Text] [Related]
2. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Function and Quality of Life in Parkinson's Disease: A Cross-Sectional Study.
Tang Y; Liang X; Han L; Peng F; Shen B; Yu H; Shen Y; Shen C; Yu J; Wang J
J Parkinsons Dis; 2020; 10(3):1209-1216. PubMed ID: 32568115
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J
Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399
[TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
Hobson P; Meara J
Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
[TBL] [Abstract][Full Text] [Related]
6. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
[TBL] [Abstract][Full Text] [Related]
8. Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.
Hsu YF; Lin SP; Chu YT; Tsai YT; Huang JW; Phoa FKH; Wu RM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542526
[TBL] [Abstract][Full Text] [Related]
9. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
[TBL] [Abstract][Full Text] [Related]
10. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
Domellöf ME; Ekman U; Forsgren L; Elgh E
Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
[TBL] [Abstract][Full Text] [Related]
11. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
[TBL] [Abstract][Full Text] [Related]
12. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ;
J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781
[TBL] [Abstract][Full Text] [Related]
13. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
[TBL] [Abstract][Full Text] [Related]
14. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
15. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.
Li CH; Chen TF; Peng PL; Lin CH
J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282
[TBL] [Abstract][Full Text] [Related]
16. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease.
Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC
J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167
[TBL] [Abstract][Full Text] [Related]
17. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
[TBL] [Abstract][Full Text] [Related]
18. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease.
Peng Z; Dong S; Tao Y; Huo Y; Zhou Z; Huang W; Qu H; Liu J; Chen Y; Xu Z; Wang Y; Zhou H
Parkinsonism Relat Disord; 2018 Oct; 55():68-74. PubMed ID: 29908727
[TBL] [Abstract][Full Text] [Related]
20. Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease.
Kamble N; Bhattacharya A; Hegde S; Vidya N; Gothwal M; Yadav R; Pal PK
Behav Brain Res; 2022 Mar; 422():113733. PubMed ID: 34998797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
